Clinical Trials Browser

Phase 2 × OTHER × Advanced Non-squamous Non-small-cell Lung Cancer × Clear all

NCT03190239 2024-02-28

XQonc-007

Phase 2 Withdrawn

Advanced Non-squamous Non-small-cell Lung Cancer

NCT06028633 2023-09-13

Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients

Phase 2 Not yet recruiting

Advanced Non-squamous Non-small-cell Lung Cancer